Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension-Reference-Cited by-同舟云学术

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension

Published:2017-07-25 Issue:8 Volume:18 Page:1609
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Jung Christian,Grün Katja,Betge Stefan,Pernow John,Kelm Malte,Muessig Johanna,Masyuk Maryna,Kuethe Friedhelm,Ndongson-Dongmo Bernadin,Bauer Reinhard,Lauten Alexander,Schulze P.,Berndt Alexander,Franz Marcus

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/8/1609/pdf

Reference44 articles.

1. Definitions and Diagnosis of Pulmonary Hypertension

2. Updated Clinical Classification of Pulmonary Hypertension

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

4. The pathogenesis of pulmonary hypertension – an update

5. The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating Nitrite-Derived S-Nitrosothiol Formation in the Upper Gastrointestinal Tract in the Therapy of Cardiovascular Diseases;Antioxidants;2024-06-04

2. RNA methylation, metabolic reprogramming and pulmonary hypertension;Chinese Science Bulletin;2023-12-01

3. Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases;Cell Death Discovery;2022-10-08

4. Applications of the ultrasound‐guided nerve block technique for nonanalgesic effects;Ibrain;2022-08-15

5. The role of immune cells in pulmonary hypertension: Focusing on macrophages;Human Immunology;2022-02